Technical Analysis for HZNP - Horizon Pharma, Inc.

Grade Last Price % Change Price Change
grade B 71.67 -5.50% -4.17
HZNP closed down 5.5 percent on Tuesday, August 11, 2020, on 1.58 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical HZNP trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Calm After Storm Range Contraction -5.50%
Upper Bollinger Band Walk Strength -5.50%
Inside Day Range Contraction -5.50%
Wide Bands Range Expansion -5.50%
Above Upper BB Strength -5.50%
Overbought Stochastic Strength -5.50%
Upper Bollinger Band Touch Strength -5.50%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Horizon Pharma, Inc., a specialty pharmaceutical company, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. The company offers DUEXIS, a proprietary tablet formulation for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis, and to decrease the risk of developing upper gastrointestinal ulcers in patients who are taking ibuprofen for these indications. It also provides LODOTRA/RAYOS, a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe active rheumatoid arthritis in adults when accompanied by morning stiffness, as well as approved for the treatment of polymyalgia rheumatica, psoriatic arthritis, ankylosing spondylitis, asthma, chronic obstructive pulmonary disease, and other conditions. The company was founded in 2005 and is headquartered in Deerfield, Illinois.
Medicine Health Pharmaceutical Pain Autoimmune Diseases Rheumatoid Arthritis Osteoarthritis Asthma Inflammatory Diseases Arthritis Chronic Obstructive Pulmonary Disease Rheumatology

Is HZNP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 78.93
52 Week Low 23.81
Average Volume 2,849,117
200-Day Moving Average 40.21
50-Day Moving Average 56.70
20-Day Moving Average 63.25
10-Day Moving Average 68.06
Average True Range 3.69
ADX 45.11
+DI 36.48
-DI 16.01
Chandelier Exit (Long, 3 ATRs ) 67.86
Chandelier Exit (Short, 3 ATRs ) 65.34
Upper Bollinger Band 76.68
Lower Bollinger Band 49.82
Percent B (%b) 0.81
BandWidth 42.47
MACD Line 4.94
MACD Signal Line 3.75
MACD Histogram 1.1914
Fundamentals Value
Market Cap 11.7 Billion
Num Shares 163 Million
EPS -2.70
Price-to-Earnings (P/E) Ratio -26.54
Price-to-Sales 2.16
Price-to-Book 2.16
PEG Ratio 0.99
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 79.53
Resistance 3 (R3) 80.10 78.05 78.22
Resistance 2 (R2) 78.05 76.05 77.77 77.78
Resistance 1 (R1) 74.86 74.81 73.84 74.29 77.35
Pivot Point 72.81 72.81 72.30 72.53 72.81
Support 1 (S1) 69.62 70.81 68.60 69.05 65.99
Support 2 (S2) 67.57 69.57 67.29 65.56
Support 3 (S3) 64.38 67.57 65.12
Support 4 (S4) 63.81